Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients

Completed · Not applicable

Conditions studied: Lupus Nephritis, Lupus Erythematosus, Systemic

In brief

This study will collect high-quality randomized controlled data from a nationally representative sample of practicing rheumatologists to determine how they currently manage patients with SLE (systemic lupus erythematosus) and how the results of DxTerity's IFN-1 (interferon type I) test change clinical decision making.

Key facts

Study ID

NCT04266860

Run by

Qure Healthcare, LLC

People needed

166

Starts

2012-03-01

Expected to finish

2013-03-01

Last updated by the study team

2020-09-16

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Board-certified in rheumatology for at least two years
• Averaging at least 20 hours per week of clinical and patient care duties over the last six months
• Practicing in the U.S.
• English speaking
• Access to the internet
• Informed, signed and voluntarily consented to be in the study

You may not qualify if…

• Non-English speaking
• Practicing in an academic setting
• Unable to access the internet
• Not practicing in the U.S.
• Not averaging at least 20 hours per week of clinical or patient care duties over the last six months
• Do not voluntarily consent to be in the study

Where it is running

• QURE Healthcare — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.